← All trials
NCT05037266
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 20, 2021
- Primary completion
- Apr 30, 2022
- Completion date
- Apr 30, 2024
- First posted
- Sep 8, 2021
- Last posted
- Nov 24, 2021
- Enrollment
- 120
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of LyonLead sponsor
- Centre Hospitalier de Saint-EtienneOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.